Early erythropoietin deficiency in diabetic kidney lesion


Cite item

Full Text

Abstract

Aim. To evaluate the renal production of erythropoietin (EPO) in relation to filtration function in patients with diabetic kidney lesion. Subjects and methods. The investigation enrolled 183 patients with types 1 and 2 diabetes mellitus (DM), of whom 128 were diagnosed as having diabetic kidney lesion. Serum EPO levels were measured by enzyme immunoassay. Patients who had a glomerular filtration rate (GFR) of below 15 ml/min/1.73 m2 and received erythropoiesis-stimulating agents were excluded from the investigation. Results. The mean serum EPO levels in the patients with diabetic kidney lesion did not vary with the presence of absence of anemia, the degree of albuminuria, or GFR. A physiological inverse relationship was found between the level of EPO and that of hemoglobin in the blood of the patients with DM without kidney disease and in those with renal lesion and GFR ≥60 ml/min/1.73 m2. The magnitude of the association of the values increased as GFR was higher. The level of EPO was found to be unassociated with hemoglobin in patients with GFR <60 ml/min/1.73 m2. Conclusion. In the patients with diabetic kidney lesion, serum EPO concentrations did not depend on the stage of chronic kidney disease and the degree of albuminuria in spite of more severe anemia as renal failure progressed. These patients showed inadequate EPO production just in early diminished renal filtration function.

Full Text

Ранний дефицит эритропоэтина при диабетическом поражении почек. - Резюме. Цель исследования. Оценка продукции эритропоэтина (ЭПО) почками в зависимости от фильтрационной функции у больных с диабетическим поражением почек. Материалы и методы. В исследование включили 183 больных сахарным диабетом (СД) 1-го и 2-го типа, из которых у 128 диагностировано диабетическое поражение почек. Уровень ЭПО в сыворотке определяли методом иммуноферментного анализа. Пациентов со скоростью клубочковой фильтрации (СКФ) менее 15 мл/мин/1,73 м2 и получающих средства, стимулирующие эритропоэз, в исследование не включали. Результаты. Средние уровни ЭПО в сыворотке у больных с диабетическим поражением почек не различались в зависимости от наличия либо отсутствия анемии, выраженности альбуминурии и СКФ. Физиологическая обратная связь между уровнем ЭПО и гемоглобина в крови выявлена у больных СД без патологии почек и у пациентов с поражением почек при СКФ ≥60 мл/мин/1,73 м2. Сила ассоциации показателей увеличивалась по мере повышения СКФ. У больных с СКФ <60 мл/мин/1,73 м2 связи уровня ЭПО и гемоглобина не выявлено. Заключение. Концентрация ЭПО в сыворотке у больных с диабетическим поражением почек не зависела от стадии хронической болезни почек, выраженности альбуминурии, несмотря на усиление тяжести анемии по мере прогрессирования почечной недостаточности. У больных с диабетическим поражением почек неадекватная продукция ЭПО наблюдается уже при начальном снижении фильтрационной функции почек.
×

References

  1. International Diabetes Federation Diabetes Atlas. 5th ed. Brussels 2011.
  2. Дедов И.И., Шестакова М.В. Диабетическая нефропатия. М: Универсум Паблишинг; 2000.
  3. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. М: Медицинское информационное агентство; 2009.
  4. Сахарный диабет. Острые и хронические осложнения. Под ред. И.И. Дедова, М.В. Шестаковой. М: Медицинское информационное агентство; 2011.
  5. USRDS Annual Data Report http://www.usrds.org
  6. Mohanram A., Zhang Z., Shaninfar S. et al. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 2004; 66: 1131-1138.
  7. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis 2007; 50 (Suppl. 3): S471-S530.
  8. Locatelli F., Aljama P., Canaud B. et al. Target haemoglobin to aim with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Study. Nephrol Dial Transplant 2010; 25 (9): 2846-2850.
  9. El-Achkar T.M., Ohmit S.E., McCullough P.A. et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int 2005; 67: 1483-1488.
  10. Ishimura E., Nishizawa Y., Okuto S. et al. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 1998; 11: 83-86.
  11. Levey A.S., Bosch J.P., Lewis J.B. et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Group. J Am Soc Nephrol 2000; 11: 155A.
  12. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1-S266.
  13. World health organization. Nutritional Anemia: Report of WHO Scientific Group 1968; World Health Organization. Geneva 1968.
  14. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006; 47 (Suppl. 3): S1-S145.
  15. Locatelli F., Aljama P., Barany P. et al. Revised European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 (Suppl. 2): ii1-ii47.
  16. Ермоленко В.М., Иващенко М.А. Уремия и эритропоэтин. М 2000.
  17. Astor B.C., Muntner P., Levin A. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Int Med 2002; 162: 1401-1408.
  18. El-Achkar T.M., Ohmit S.E., McCullough P.A. et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int 2005; 67: 1483-1488.
  19. Шестакова М.В., Мартынов С.А., Ильин А.В. и др. Анемия при диабетической нефропатии: распространенность, клинические и патофизиологические особенности. Тер арх 2008; 6: 41-47.
  20. Румянцев А.Г., Морщакова Е.Ф., Павлов А.Д. Эритропоэтин в диагностике, профилактике и лечении анемий. M 2003.
  21. Radtke H.W., Claussner A., Erbes P.M. et al. Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function. Blood 1979; 54: 877-884.
  22. Chandra M., Clemons G.K., McVicar M.I. Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 1988; 113: 1015-1021.
  23. Bosman D.R., Winkler A.S., Marsden J.T. et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24: 495-499.
  24. Craig K.J., Williams J.D., Riley S.G. et al. Anemia and diabetes in the absence of nephropathy. Diabetes Care 2005; 28: 1118-1123.
  25. Bordier L., Le Berre J.P., Garcia C. et al. Influence of blood pressure level on urinary albumin excretion rate and erythropoietin production in diabetic patients. Arch Mal Coeur Vaiss 1999; 7-8: 701-704.
  26. Mojiminiyi O.A., Abdella N.A., Zaki M.Y. et al. Prevalence and associations of low plasma erythropoietin in patients with type 2 diabetes mellitus. Diabetic Med 2006; 23: 839-844.
  27. Cotroneo P., Maria Ricerca B., Todaro L. et al. Blunted erythropoietin response to anemia in patients with type 1 diabetes. Diabet Metab Res Rev 2000; 16: 172-176.
  28. Fehr T., Ammann P., Garzoni D. et al. Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia, Kidney Int 2004; 66: 1206-1211.
  29. Artunc F., Risler A. Serum erythropoietin concentrations and responses to anemia in patients with or without chronic kidney disease. Nephrol Dial Transplant 2007; 22: 2900-2908.
  30. Inoue A., Babazano T., Suzuki K., Iwamoto Y. Albuminuria is an independent predictor of decreased serum erythropoietin levels in type 2 diabetic patients. Nephrol Dial Transplant 2007; 22: 287-288.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies